ArticleBioinformatics (Oxford, England)2014
A gradient-boosting approach for filtering de novo mutations in parent-offspring trios.
Article in Bioinformatics (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 38 citations in OpenAlex.
- A practical framework for predicting splicing single nucleotide variants in exome sequencing.NAR genomics and bioinformatics · 2025Article
- Efficient identification of de novo mutations in family trios: a consensus-based informatic approach.Life science alliance · 2025Article
- Systems biology and experimental validation indicate DDIT4, FOXO1, and STAT3 as shared key genes linking osteoporosis and sarcopenia.Frontiers in genetics · 2025Article
- Automated Identification of GermlinebioRxiv : the preprint server for biology · 2024Article
- Effective analysis of job satisfaction among medical staff in Chinese public hospitals: a random forest model.Frontiers in public health · 2024Article
- Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder.Molecular psychiatry · 2023Article
- inGAP-family: Accurate Detection of Meiotic Recombination Loci and Causal Mutations by Filtering Out Artificial Variants due to Genome Complexities.Genomics, proteomics & bioinformatics · 2022Article
- Where Do We Stand in Regularization for Life Science Studies?Journal of computational biology : a journal of computational molecular cell biology · 2022Article
- Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder.Nature communications · 2021Article
- Contributions of de novo variants to systemic lupus erythematosus.European journal of human genetics : EJHG · 2021Article
- Effective Analysis of Inpatient Satisfaction: The Random Forest Algorithm.Patient preference and adherence · 2021Article
- Filtering de novo indels in parent-offspring trios.BMC bioinformatics · 2020Article
- Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk.Nature genetics · 2019Article
- Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes.NPJ genomic medicine · 2019Article
- Exome sequencing of multiple-sclerosis patients and their unaffected first-degree relatives.BMC research notes · 2017Article
- Joint detection of copy number variations in parent-offspring trios.Bioinformatics (Oxford, England) · 2016Article
- McTwo: a two-step feature selection algorithm based on maximal information coefficient.BMC bioinformatics · 2016Article
- Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA.American journal of human genetics · 2016Article
- A Bayesian framework for de novo mutation calling in parents-offspring trios.Bioinformatics (Oxford, England) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
Abstract
motivationWhole-genome and -exome sequencing on parent-offspring trios is a powerful approach to identifying disease-associated genes by detecting de novo mutations in patients. Accurate detection of de novo mutations from sequencing data is a critical step in trio-based genetic studies. Existing bioinformatic approaches usually yield high error rates due to sequencing artifacts and alignment issues, which may either miss true de novo mutations or call too many false ones, making downstream validation and analysis difficult. In particular, current approaches have much worse specificity than sensitivity, and developing effective filters to discriminate genuine from spurious de novo mutations remains an unsolved challenge.
resultsIn this article, we curated 59 sequence features in whole genome and exome alignment context which are considered to be relevant to discriminating true de novo mutations from artifacts, and then employed a machine-learning approach to classify candidates as true or false de novo mutations. Specifically, we built a classifier, named De Novo Mutation Filter (DNMFilter), using gradient boosting as the classification algorithm. We built the training set using experimentally validated true and false de novo mutations as well as collected false de novo mutations from an in-house large-scale exome-sequencing project. We evaluated DNMFilter's theoretical performance and investigated relative importance of different sequence features on the classification accuracy. Finally, we applied DNMFilter on our in-house whole exome trios and one CEU trio from the 1000 Genomes Project and found that DNMFilter could be coupled with commonly used de novo mutation detection approaches as an effective filtering approach to significantly reduce false discovery rate without sacrificing sensitivity. AVAILABILITY: The software DNMFilter implemented using a combination of Java and R is freely available from the website at http://humangenome.duke.edu/software.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.